Business Standard

PharmEasy listing pull-out a sign of start-up fatigue: Market experts

Shares of new-age companies have dropped more than 60% amid liquidity squeeze.

IPO
Premium

PharmEasy has now said it will instead raise money from existing shareholders through a rights offering.

Sundar SethuramanSamie Modak Thiruvananthapuram/Mumbai
India’s largest online pharmacy PharmEasy’s decision to cancel its listing plans reinforces the problems start-ups face when it comes to tapping the public markets.

Bolstered by successful listings of Zomato, Nykaa, and Policy Bazaar, PharmEasy parent firm API Holdings filed for a Rs 6,250-crore initial public offering (IPO) with markets regulator Securities and Exchange Board of India in November 2021.

Since then, the market has turned on its head with shares of new-age companies dropping more than 60 per cent from their highs amid tightening liquidity conditions. This queered the pitch for new-age companies, such as Oravel Stays (Oyo Hotels
Topics : PharmEasy

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 23 2022 | 12:15 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com